Oral thrombin inhibitors designed at Knoll (Abbott) inhibit both free and fibrin-bound thrombin July 12, 2001
Factor VIII retroviral construct safe and potentially effective in hemophilia A patients July 12, 2001
P2T antagonist AR-C69931 acts synergistically with PGE1 to inhibit Ca2+ mobilization in platelets July 12, 2001